Article
Dose response for T-cell receptor (TCR) mutants in patients repeatedly treated with 131I for thyroid cancer.
Mutation research - 14 Apr 2004
Vershenya Stanislav, Biko Johannes, Drozd Valentina, Lorenz Reinhard, Reiners Christoph, Hempel Klaus
Abstract excerpt
The T-cell receptor mutant frequency (TCR-Mf) was measured in 53 young adults, who were treated with radioiodine for thyroid cancer. Patients came from the southern part of Belarus. This region had suffered the most from the Chernobyl Disaster. TCR-Mf was determined by flow cytometry before and after 1 to maximal 10 treatments. Before treatment, TCR-Mf of patients was 2.0 x 10(-14). This Mf value is in the same...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
